Logo image of CMLS

CUMULUS MEDIA INC-CL A (CMLS) Stock Fundamental Analysis

NASDAQ:CMLS - Nasdaq - US2310828015 - Common Stock - Currency: USD

0.189  -0.04 (-18.95%)

After market: 0.16 -0.03 (-15.34%)

Fundamental Rating

2

Taking everything into account, CMLS scores 2 out of 10 in our fundamental rating. CMLS was compared to 98 industry peers in the Media industry. CMLS has a bad profitability rating. Also its financial health evaluation is rather negative. CMLS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CMLS had negative earnings in the past year.
CMLS had a negative operating cash flow in the past year.
In multiple years CMLS reported negative net income over the last 5 years.
Of the past 5 years CMLS 4 years had a positive operating cash flow.
CMLS Yearly Net Income VS EBIT VS OCF VS FCFCMLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

CMLS has a Return On Assets of -25.32%. This is in the lower half of the industry: CMLS underperforms 78.35% of its industry peers.
The Return On Equity of CMLS (-4075.01%) is worse than 81.44% of its industry peers.
CMLS has a worse Return On Invested Capital (0.01%) than 63.92% of its industry peers.
CMLS had an Average Return On Invested Capital over the past 3 years of 2.36%. This is significantly below the industry average of 7.45%.
Industry RankSector Rank
ROA -25.32%
ROE -4075.01%
ROIC 0.01%
ROA(3y)-10.83%
ROA(5y)-6.94%
ROE(3y)-1370.73%
ROE(5y)-824.61%
ROIC(3y)2.36%
ROIC(5y)2.14%
CMLS Yearly ROA, ROE, ROICCMLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

CMLS has a Operating Margin of 0.01%. This is in the lower half of the industry: CMLS underperforms 63.92% of its industry peers.
CMLS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 60.80%, CMLS is in the better half of the industry, outperforming 74.23% of the companies in the same industry.
In the last couple of years the Gross Margin of CMLS has remained more or less at the same level.
Industry RankSector Rank
OM 0.01%
PM (TTM) N/A
GM 60.8%
OM growth 3Y-89.25%
OM growth 5Y-76.27%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y-0.89%
CMLS Yearly Profit, Operating, Gross MarginsCMLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CMLS is destroying value.
The number of shares outstanding for CMLS has been increased compared to 1 year ago.
Compared to 5 years ago, CMLS has less shares outstanding
Compared to 1 year ago, CMLS has a worse debt to assets ratio.
CMLS Yearly Shares OutstandingCMLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CMLS Yearly Total Debt VS Total AssetsCMLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CMLS has an Altman-Z score of 0.48. This is a bad value and indicates that CMLS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CMLS (0.48) is worse than 63.92% of its industry peers.
A Debt/Equity ratio of 96.41 is on the high side and indicates that CMLS has dependencies on debt financing.
With a Debt to Equity ratio value of 96.41, CMLS is not doing good in the industry: 81.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 96.41
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACC0
WACC8.05%
CMLS Yearly LT Debt VS Equity VS FCFCMLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 1.85 indicates that CMLS should not have too much problems paying its short term obligations.
CMLS's Current ratio of 1.85 is fine compared to the rest of the industry. CMLS outperforms 63.92% of its industry peers.
CMLS has a Quick Ratio of 1.85. This is a normal value and indicates that CMLS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CMLS (1.85) is better than 63.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
CMLS Yearly Current Assets VS Current LiabilitesCMLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for CMLS have decreased strongly by -65.57% in the last year.
The Revenue has decreased by -2.07% in the past year.
The Revenue has been decreasing by -5.77% on average over the past years.
EPS 1Y (TTM)-65.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.18%
Revenue 1Y (TTM)-2.07%
Revenue growth 3Y-3.36%
Revenue growth 5Y-5.77%
Sales Q2Q%-6.35%

3.2 Future

CMLS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.18% yearly.
CMLS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.60% yearly.
EPS Next Y3.11%
EPS Next 2Y15.1%
EPS Next 3Y7.18%
EPS Next 5YN/A
Revenue Next Year-8.62%
Revenue Next 2Y-2.1%
Revenue Next 3Y-1.18%
Revenue Next 5Y0.6%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMLS Yearly Revenue VS EstimatesCMLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CMLS Yearly EPS VS EstimatesCMLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10 20 30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CMLS. In the last year negative earnings were reported.
Also next year CMLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CMLS Price Earnings VS Forward Price EarningsCMLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMLS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.3
CMLS Per share dataCMLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.1%
EPS Next 3Y7.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CMLS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CUMULUS MEDIA INC-CL A

NASDAQ:CMLS (5/1/2025, 8:53:06 PM)

After market: 0.16 -0.03 (-15.34%)

0.189

-0.04 (-18.95%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners40.09%
Inst Owner Change0%
Ins Owners10.97%
Ins Owner Change0%
Market Cap3.30M
Analysts45.71
Price Target11.22 (5836.51%)
Short Float %0.72%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.38%
Min EPS beat(2)-10.75%
Max EPS beat(2)33.5%
EPS beat(4)2
Avg EPS beat(4)-42.91%
Min EPS beat(4)-231.51%
Max EPS beat(4)37.11%
EPS beat(8)4
Avg EPS beat(8)-21.47%
EPS beat(12)5
Avg EPS beat(12)-17.82%
EPS beat(16)8
Avg EPS beat(16)-20.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-2.28%
Max Revenue beat(2)-2.06%
Revenue beat(4)0
Avg Revenue beat(4)-2.23%
Min Revenue beat(4)-2.51%
Max Revenue beat(4)-2.06%
Revenue beat(8)0
Avg Revenue beat(8)-1.8%
Revenue beat(12)2
Avg Revenue beat(12)-0.91%
Revenue beat(16)3
Avg Revenue beat(16)-0.79%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-3.2%
EPS NQ rev (3m)-10.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.31%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-4.57%
Revenue NY rev (1m)-5.3%
Revenue NY rev (3m)-7.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB N/A
EV/EBITDA 10.3
EPS(TTM)-4.52
EYN/A
EPS(NY)-2.36
Fwd EYN/A
FCF(TTM)-1.29
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS47.42
BVpS0.4
TBVpS-33.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.32%
ROE -4075.01%
ROCE 0.01%
ROIC 0.01%
ROICexc 0.01%
ROICexgc 0.02%
OM 0.01%
PM (TTM) N/A
GM 60.8%
FCFM N/A
ROA(3y)-10.83%
ROA(5y)-6.94%
ROE(3y)-1370.73%
ROE(5y)-824.61%
ROIC(3y)2.36%
ROIC(5y)2.14%
ROICexc(3y)2.54%
ROICexc(5y)2.34%
ROICexgc(3y)8%
ROICexgc(5y)7.4%
ROCE(3y)2.99%
ROCE(5y)2.71%
ROICexcg growth 3Y-88.54%
ROICexcg growth 5Y-74.64%
ROICexc growth 3Y-88.06%
ROICexc growth 5Y-75.01%
OM growth 3Y-89.25%
OM growth 5Y-76.27%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y-0.89%
F-Score3
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 96.41
Debt/FCF N/A
Debt/EBITDA 11.32
Cap/Depr 32.92%
Cap/Sales 2.35%
Interest Coverage 0
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z 0.48
F-Score3
WACC8.05%
ROIC/WACC0
Cap/Depr(3y)43.63%
Cap/Depr(5y)45.37%
Cap/Sales(3y)2.85%
Cap/Sales(5y)2.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.18%
EPS Next Y3.11%
EPS Next 2Y15.1%
EPS Next 3Y7.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.07%
Revenue growth 3Y-3.36%
Revenue growth 5Y-5.77%
Sales Q2Q%-6.35%
Revenue Next Year-8.62%
Revenue Next 2Y-2.1%
Revenue Next 3Y-1.18%
Revenue Next 5Y0.6%
EBIT growth 1Y-99.71%
EBIT growth 3Y-89.62%
EBIT growth 5Y-77.64%
EBIT Next Year1480.77%
EBIT Next 3Y147.42%
EBIT Next 5Y86.44%
FCF growth 1Y-429.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-109.85%
OCF growth 3YN/A
OCF growth 5YN/A